US-based vaccine company developer of HEPLISAV-B (approved adult Hepatitis B vaccine) and vaccine candidate Z-1018 for shingles (phase 1/2), with additional vaccine pipeline projects.
Industries
Frequently Asked Questions
What industries does Dynavax Technologies Corporation operate in?
Dynavax Technologies Corporation operates in the following industries: biotechnology, vaccines, pharmaceuticals.